Paul Fisher, M.D.
NPI 1821034547 · Diagnostic Radiology Physician · Stony Brook, NY
Enrolled with Medicare as Practitioner - Diagnostic Radiology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1821034547
- Entity type
- Individual
- Primary specialty
- Diagnostic Radiology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 199823 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
597 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Screening 3d Breast Mammography77063 | 212 | $31 |
| Screening Mammography77067 | 212 | $39 |
| Screening 3d Breast Mammography77063 | 44 | $58 |
| Screening Mammography77067 | 44 | $145 |
| Complete Ultrasound Scan of 1 Breast76641 | 38 | $57 |
| Diagnostic Digital Breast Tomosynthesis, Unilateral Or Bilateral (list Separately in Addition to 77065 Or 77066)G0279 | 19 | $31 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,000 across 1 record (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-21
- Last updated
- 2022-04-27
- Certified
- 2022-04-27
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.